Potential Predictors for Disease Progression and Medication Evaluation of 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Sheng Zhang(Shanghai Jiao Tong University), Dechang Chen(Shanghai Jiao Tong University), Lidi Zhang(Shanghai Jiao Tong University), Xuan Dong(The Ohio State University), Jieming Qu(Shanghai Jiao Tong University), Mengmeng Shi(Shanghai Jiao Tong University), Zhixiong Wu(Fudan University), Jiao Liu(Shanghai Jiao Tong University), Tao Wang(Shanghai Jiao Tong University), Guang Li(Wuhan University), Limin Chen(Shanghai Jiao Tong University), You Shang(Huazhong University of Science and Technology), Junhua Zheng(Shanghai Jiao Tong University), Sisi Huang(Shanghai Jiao Tong University), Mei Meng(Shanghai Jiao Tong University), Qingyuan Yang(Shanghai Jiao Tong University), Yanping Xu(Shanghai Jiao Tong University), Mengyuan Diao(Hangzhou First People's Hospital), Jingya Zhao(Shanghai Jiao Tong University), Wenzhe Li(Peking University), Zhenliang Wen(Shanghai Jiao Tong University)
Cited by 6
Related Papers
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
|Scientific Reports|2017|453
NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies
|Frontiers in Cellular Neuroscience|2017|452
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
|Nature Communications|2020|432
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19
|Immunity|2020|387